COMMUNIQUÉS West-GlobeNewswire

Teligent, Inc. Announces Second Quarter 2019 Results
05/08/2019
BUENA, N.J., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second quarter ended June 30, 2019 [...]
Bellicum Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Operational Update
05/08/2019
Interim safety and activity data for BPX-601 presented at American Society of Clinical Oncology (ASCO) Annual Meeting Rivo-cel TM achieved primary endpoint in BP-004 European registrational trial HOUSTON, Aug. 05, 2019 [...]
OrthoPediatrics Corp. to Participate in 4th Annual Needham Med Tech & Diagnostics Conference
05/08/2019
WARSAW, Ind., Aug. 05, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today that Mark Throdahl [...]
Fulgent Genetics Reports Second Quarter 2019 Financial Results
05/08/2019
Second Quarter 2019 Results : Record billable tests of 16,369, growing 187% year over year Record revenue of $8.4 million, growing 56% year over year Gross Margin improves more than 12 percentage points sequentially; [...]
GenMark Diagnostics Reports Second Quarter 2019 Results
05/08/2019
CARLSBAD, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the [...]
Assembly Biosciences Reports Second Quarter 2019 Financial Results and Recent Highlights
05/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and [...]
Diversicare Announces 2019 Second Quarter Results
05/08/2019
BRENTWOOD, Tenn., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR), a premier provider of long-term care services, today announced its results for the second quarter ended June 30, [...]
Novavax Reaches Agreement with the FDA on Pivotal Phase 3 Trial Design for NanoFlu
05/08/2019
Clinical trial expected to initiate in the fall of 2019 GAITHERSBURG, Md., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (NASDAQ: NVAX), a late-stage biotechnology company developing next-generation vaccines for [...]
ChemoCentryx Reports Second Quarter 2019 Financial Results and Recent Highlights
05/08/2019
-- Topline data from pivotal ADVOCATE Phase III trial of C5a receptor inhibitor avacopan in ANCA Vasculitis on track for Q4 2019 -- -- Completed enrollment in LUMINA 1 Phase II trial of CCR2 inhibitor CCX140 in Focal [...]
Harpoon Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
05/08/2019
Continued enrollment and dose escalation of Phase 1 trial for HPN424, Harpoon’s lead TriTAC product candidate in development for the treatment of prostate cancer Initiated Phase 1/2a clinical trial for HPN536, Harpoon’s [...]
Shockwave Medical Reports Second Quarter 2019 Financial Results
05/08/2019
SANTA CLARA, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified [...]
Entasis Therapeutics Appoints Dr. Howard Mayer to Board of Directors
05/08/2019
WALTHAM, Mass., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, [...]
Radius Health Initiates Phase 3 wearABLe Study of Abaloparatide-Patch in Postmenopausal Osteoporosis Patients at High Risk for Fracture
05/08/2019
Abaloparatide-Patch patient assessment study results demonstrated high patient acceptability and self-administration accuracy over a 29-day period Levels of PINP, a biomarker for bone formation, after one month in [...]
United Health Products Announces the Completion of Human Trial Surgery Enrollment
05/08/2019
HENDERSON, Nev., Aug. 05, 2019 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound [...]
Opthea to Host Investor Teleconference
05/08/2019
MELBOURNE, Australia, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT) will host a conference call to discuss the results of the Company’s Phase 2b clinical trial of OPT-302 in combination with Lucentis ® ( [...]
Major shareholder announcement
05/08/2019
Company announcement No. 24/2019 Orphazyme A/S Ole Maaløes Vej 3 DK-2200 Copenhagen N www.orphazyme.com Company Registration No. 32266355 Copenhagen, August 5, 2019 – Orphazyme A/S, a biopharmaceutical company dedicated [...]
Corizon Health Chosen to Continue Services for Fayette County, Kentucky
05/08/2019
BRENTWOOD, Tenn., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Corizon Health recently won a competitive bidding process to continue providing medical services for offenders in the Community Corrections Center operated by the [...]
Dr. Gary Kaplan to Present Keynote at The Governance Institute’s October Leadership Conference
05/08/2019
Influential physician executive and healthcare leader will challenge boards with improving quality, safety, and efficiency LINCOLN, Neb., Aug. 05, 2019 (GLOBE NEWSWIRE) -- The Governance Institute , a service of NRC [...]
BioTelemetry, Inc. Names Manish Wadhwa, M.D., F.H.R.S. Chief Medical Officer
05/08/2019
MALVERN, Pa., Aug. 05, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of [...]

Pages